To date, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has infected about 251 million individuals and claimed more than five million lives [...]
It has been twenty months since the coronavirus disease 2019 (COVID-19) pandemic began, with 243 million people infected, 4.94 million deaths, and 6.3 [...]
The AIDS Clinical Trials Group (ACTG), the largest global HIV research network, which has expanded its focus to include evaluating outpatient treatment for [...]
A new study published on the preprint server bioRxiv* describes how monoclonal antibodies raised against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) [...]
Serological assays for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibodies are increasingly available for detecting infection. However, there are critical gaps in [...]
The Native Antigen Company, part of LGC Clinical Diagnostics and one of the world’s leading suppliers of reagents that enables research into diagnostics [...]
AMSBIO has launched a comprehensive range of cytosections that offer a verified, reproducible and renewable source of positive/negative controls where the expression of [...]